Inventor · disambiguated record
Seok-Ki Choi
Also filed as: CHOI SEOK KI
76 granted patents·9 pending applications·1,062 citations·filing 1995–2024
99Inventor score
Top patents by PatentIndex Score
85 records- 0198US7879896B2Dual-acting imidazole antihypertensive agentsTHERAVANCE INC·Filed 2008·Granted Feb 1, 2011·53 cites·30 claims
- 0298US7777077B2Dual-acting antihypertensive agentsTHERAVANCE INC·Filed 2008·Granted Aug 17, 2010·34 cites·34 claims
- 0397US8013005B2Dual-acting antihypertensive agentsTHERAVANCE INC·Filed 2008·Granted Sep 6, 2011·42 cites·22 claims
- 0497US7834041B2Dual-acting antihypertensive agentsTHERAVANCE INC·Filed 2008·Granted Nov 16, 2010·29 cites·24 claims
- 0597US7375114B2Quinolinone-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2005·Granted May 20, 2008·41 cites·17 claims
- 0696US6541669B1β2-adrenergic receptor agonistsTHERAVANCE INC·Filed 1999·Granted Apr 1, 2003·114 cites·23 claims
- 0795US6593497B1β2-adrenergic receptor agonistsTHERAVANCE INC·Filed 2000·Granted Jul 15, 2003·56 cites·8 claims
- 0894US7989484B2Dual-acting antihypertensive agentsTHERAVANCE INC·Filed 2009·Granted Aug 2, 2011·25 cites·21 claims
- 0994US7863309B2Dual-acting antihypertensive agentsTHERAVANCE INC·Filed 2009·Granted Jan 4, 2011·27 cites·27 claims
- 1094US7759363B2Benzimidazole-carboxamide compounds as 5-HT4, receptor agonistsTHERAVANCE INC·Filed 2006·Granted Jul 20, 2010·18 cites·18 claims
- 1194US7396933B2Quinolinone-carboxamide compoundsTHERAVANCE INC·Filed 2005·Granted Jul 8, 2008·28 cites·13 claims
- 1294US7351704B2Indazole-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2005·Granted Apr 1, 2008·25 cites·19 claims
- 1394US6756400B2Sodium channel modulatorsTHERAVANCE INC·Filed 2001·Granted Jun 29, 2004·36 cites·14 claims
- 1494US6713651B1β2-adrenergic receptor agonistsTHERAVANCE INC·Filed 1999·Granted Mar 30, 2004·49 cites·9 claims
- 1593US8212052B2Dual-acting benzoimidazole antihypertensive agentsCHOI SEOK-KI·Filed 2008·Granted Jul 3, 2012·23 cites·23 claims
- 1693US7419989B2Indazole-carboxamide compoundsTHERAVANCE INC·Filed 2005·Granted Sep 2, 2008·19 cites·12 claims
- 1793US7399862B25-HT4 receptor agonist compoundsTHERAVANCE INC·Filed 2005·Granted Jul 15, 2008·26 cites·12 claims
- 1893US6646012B2Sodium channel modulatorsTHERAVANCE INC·Filed 2002·Granted Nov 11, 2003·30 cites·16 claims
- 1992US8377964B2Benzimidazole-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2010·Granted Feb 19, 2013·10 cites·17 claims
- 2092US8158659B2Dual-acting imidazole antihypertensive agentsALLEGRETTI PAUL·Filed 2010·Granted Apr 17, 2012·11 cites·32 claims
- 2192US7763637B2Quinolinone-carboxamide compounds as 5-HT4, receptor agonistsTHERAVANCE INC·Filed 2008·Granted Jul 27, 2010·12 cites·19 claims
- 2292US7317022B2Benzoimidazolone-carboxamide compounds as 5-HT4 receptors agonistsTHERAVANCE INC·Filed 2006·Granted Jan 8, 2008·19 cites·15 claims
- 2392US6479498B1Sodium channel drugs and usesTHERAVANCE INC·Filed 2001·Granted Nov 12, 2002·36 cites·12 claims
- 2491US6362371B1β2- adrenergic receptor agonistsADVANCED MEDICINE INC·Filed 1999·Granted Mar 26, 2002·61 cites·2 claims
- 2590US7534889B25-HT4 receptor agonist compoundsTHERAVANCE INC·Filed 2008·Granted May 19, 2009·13 cites·16 claims
- 2690US7226950B2Sodium channel modulatorsTHERAVANCE INC·Filed 2006·Granted Jun 5, 2007·7 cites·11 claims
- 2790US7183323B2Sodium channel modulatorsTHERAVANCE INC·Filed 2004·Granted Feb 27, 2007·20 cites·5 claims
- 2888US7498442B2Quinolinone-carboxamide compoundsTHERAVANCE INC·Filed 2008·Granted Mar 3, 2009·10 cites·10 claims
- 2988US7446114B2Quinolinone compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2006·Granted Nov 4, 2008·10 cites·15 claims
- 3087US8962653B2Quinolinone-carboxamide compounds as 5-HT4 receptor agonistsMARQUESS DANIEL·Filed 2013·Granted Feb 24, 2015·5 cites·11 claims
- 3187US7217738B2β2-adrenergic receptor agonistsTHERAVANCE INC·Filed 2005·Granted May 15, 2007·6 cites·9 claims
- 3286US8344013B2Dual-acting imidazole antihypertensive agentsTHERAVANCE INC·Filed 2012·Granted Jan 1, 2013·4 cites·7 claims
- 3386US8236846B2Dual-acting antihypertensive agentsALLEGRETTI PAUL·Filed 2011·Granted Aug 7, 2012·5 cites·24 claims
- 3486US6683115B2β2-adrenergic receptor agonistsTHERAVANCE INC·Filed 2001·Granted Jan 27, 2004·16 cites·24 claims
- 3585US7875629B2Quinolinone compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2008·Granted Jan 25, 2011·6 cites·11 claims
- 3685US7132422B2Sodium channel modulatorsTHERAVANCE INC·Filed 2005·Granted Nov 7, 2006·2 cites·11 claims
- 3784US8569351B2Dual-acting benzyl triazole antihypertensive agents having angiotensin II type receptor antagonist activity and neprilysin-inhibition activityALLEGRETTI PAUL·Filed 2012·Granted Oct 29, 2013·3 cites·3 claims
- 3884US8309575B2Quinolinone-carboxamide compounds as 5-HT4 receptor agonistsMARQUESS DANIEL·Filed 2010·Granted Nov 13, 2012·5 cites·5 claims
- 3983US9353106B2Quinolinone-carboxamide compounds as 5-HT4 receptor agonistsMARQUESS DANIEL·Filed 2015·Granted May 31, 2016·2 cites·9 claims
- 4083US8895755B2Intermediates for preparing dual-acting benzyl triazole antihypertensive agents having angiotensin II type I receptor antagonist activity and neprilysin-inhibition activityALLEGRETTI PAUL·Filed 2013·Granted Nov 25, 2014·3 cites·1 claims
- 4183US8349875B2Dual-acting antihypertensive agentsTHERAVANCE INC·Filed 2012·Granted Jan 8, 2013·3 cites·24 claims
- 4283US8080572B2Dual-acting antihypertensive agentsCHOI SEOK-KI·Filed 2010·Granted Dec 20, 2011·5 cites·22 claims
- 4383US7105701B2β2-adrenergic receptor agonistsTHERAVANCE INC·Filed 2005·Granted Sep 12, 2006·2 cites·9 claims
- 4482US9012485B2Dual-acting imidazole antihypertensive agentsCHOI SEOK-KI·Filed 2014·Granted Apr 21, 2015·2 cites·6 claims
- 4582US7772239B2Benzoimidazolone-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2007·Granted Aug 10, 2010·4 cites·16 claims
- 4682US7329752B2Carbamate compounds as 5-HT4 receptor agonistsTHERAVANCE INC·Filed 2006·Granted Feb 12, 2008·4 cites·13 claims
- 4782US6919482B2β2-adrenergic receptor agonistsTHERAVANCE INC·Filed 2004·Granted Jul 19, 2005·13 cites·10 claims
- 4881US9873692B2Quinolinone-carboxamide compounds as 5-HT4 receptor agonistsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2017·Granted Jan 23, 2018·1 cites·2 claims
- 4981US2022274957A1Benzimidazole-carboxamide compounds as 5-ht4 receptor agonistsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2022·Application pending·0 cites
- 5080US6872741B2Sodium channel modulatorsTHERAVANCE INC·Filed 2003·Granted Mar 29, 2005·7 cites·20 claims
Showing the top 50 of 85 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Seok-Ki Choi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →